As the global economy mends, the 2021 growth of Pet Skin Disease Drugs will have significant change from previous year. According to our (Publisher) latest study, the global Pet Skin Disease Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pet Skin Disease Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Pet Skin Disease Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Pet Skin Disease Drugs market, reaching US$ million by the year 2028. As for the Europe Pet Skin Disease Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Pet Skin Disease Drugs players cover Zoetis Animal Health, Boehringer Ingelheim, Elanco, and Virbac, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Skin Disease Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Internal Medication
External Medication
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Parasitic Skin Diseases
Fungal Dermatoses
Bacterial Skin Diseases
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Zoetis Animal Health
Boehringer Ingelheim
Elanco
Virbac
Norbrook Laboratories
Dechra Veterinary Products
Vetoquinol
ALKINLAB
Truseb
Olewo
KANGZHIBO
Shanghai Hanvet Bio-Pharm
DCVET
Nanjing LANBOTO
Jindun Pharmaceutical
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Skin Disease Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Skin Disease Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Skin Disease Drugs by Country/Region, 2017, 2022 & 2028
2.2 Pet Skin Disease Drugs Segment by Type
2.2.1 Internal Medication
2.2.2 External Medication
2.3 Pet Skin Disease Drugs Sales by Type
2.3.1 Global Pet Skin Disease Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Skin Disease Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Skin Disease Drugs Sale Price by Type (2017-2022)
2.4 Pet Skin Disease Drugs Segment by Application
2.4.1 Parasitic Skin Diseases
2.4.2 Fungal Dermatoses
2.4.3 Bacterial Skin Diseases
2.4.4 Other
2.5 Pet Skin Disease Drugs Sales by Application
2.5.1 Global Pet Skin Disease Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Skin Disease Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Skin Disease Drugs Sale Price by Application (2017-2022)
3 Global Pet Skin Disease Drugs by Company
3.1 Global Pet Skin Disease Drugs Breakdown Data by Company
3.1.1 Global Pet Skin Disease Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Pet Skin Disease Drugs Sales Market Share by Company (2020-2022)
3.2 Global Pet Skin Disease Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Skin Disease Drugs Revenue by Company (2020-2022)
3.2.2 Global Pet Skin Disease Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Pet Skin Disease Drugs Sale Price by Company
3.4 Key Manufacturers Pet Skin Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Skin Disease Drugs Product Location Distribution
3.4.2 Players Pet Skin Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Skin Disease Drugs by Geographic Region
4.1 World Historic Pet Skin Disease Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Skin Disease Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Skin Disease Drugs Annual Revenue by Geographic Region
4.2 World Historic Pet Skin Disease Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Skin Disease Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Skin Disease Drugs Annual Revenue by Country/Region
4.3 Americas Pet Skin Disease Drugs Sales Growth
4.4 APAC Pet Skin Disease Drugs Sales Growth
4.5 Europe Pet Skin Disease Drugs Sales Growth
4.6 Middle East & Africa Pet Skin Disease Drugs Sales Growth
5 Americas
5.1 Americas Pet Skin Disease Drugs Sales by Country
5.1.1 Americas Pet Skin Disease Drugs Sales by Country (2017-2022)
5.1.2 Americas Pet Skin Disease Drugs Revenue by Country (2017-2022)
5.2 Americas Pet Skin Disease Drugs Sales by Type
5.3 Americas Pet Skin Disease Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Skin Disease Drugs Sales by Region
6.1.1 APAC Pet Skin Disease Drugs Sales by Region (2017-2022)
6.1.2 APAC Pet Skin Disease Drugs Revenue by Region (2017-2022)
6.2 APAC Pet Skin Disease Drugs Sales by Type
6.3 APAC Pet Skin Disease Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Skin Disease Drugs by Country
7.1.1 Europe Pet Skin Disease Drugs Sales by Country (2017-2022)
7.1.2 Europe Pet Skin Disease Drugs Revenue by Country (2017-2022)
7.2 Europe Pet Skin Disease Drugs Sales by Type
7.3 Europe Pet Skin Disease Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Skin Disease Drugs by Country
8.1.1 Middle East & Africa Pet Skin Disease Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Skin Disease Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Skin Disease Drugs Sales by Type
8.3 Middle East & Africa Pet Skin Disease Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Skin Disease Drugs
10.3 Manufacturing Process Analysis of Pet Skin Disease Drugs
10.4 Industry Chain Structure of Pet Skin Disease Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Skin Disease Drugs Distributors
11.3 Pet Skin Disease Drugs Customer
12 World Forecast Review for Pet Skin Disease Drugs by Geographic Region
12.1 Global Pet Skin Disease Drugs Market Size Forecast by Region
12.1.1 Global Pet Skin Disease Drugs Forecast by Region (2023-2028)
12.1.2 Global Pet Skin Disease Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Skin Disease Drugs Forecast by Type
12.7 Global Pet Skin Disease Drugs Forecast by Application
13 Key Players Analysis
13.1 Zoetis Animal Health
13.1.1 Zoetis Animal Health Company Information
13.1.2 Zoetis Animal Health Pet Skin Disease Drugs Product Offered
13.1.3 Zoetis Animal Health Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Zoetis Animal Health Main Business Overview
13.1.5 Zoetis Animal Health Latest Developments
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Information
13.2.2 Boehringer Ingelheim Pet Skin Disease Drugs Product Offered
13.2.3 Boehringer Ingelheim Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Boehringer Ingelheim Main Business Overview
13.2.5 Boehringer Ingelheim Latest Developments
13.3 Elanco
13.3.1 Elanco Company Information
13.3.2 Elanco Pet Skin Disease Drugs Product Offered
13.3.3 Elanco Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Elanco Main Business Overview
13.3.5 Elanco Latest Developments
13.4 Virbac
13.4.1 Virbac Company Information
13.4.2 Virbac Pet Skin Disease Drugs Product Offered
13.4.3 Virbac Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Virbac Main Business Overview
13.4.5 Virbac Latest Developments
13.5 Norbrook Laboratories
13.5.1 Norbrook Laboratories Company Information
13.5.2 Norbrook Laboratories Pet Skin Disease Drugs Product Offered
13.5.3 Norbrook Laboratories Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Norbrook Laboratories Main Business Overview
13.5.5 Norbrook Laboratories Latest Developments
13.6 Dechra Veterinary Products
13.6.1 Dechra Veterinary Products Company Information
13.6.2 Dechra Veterinary Products Pet Skin Disease Drugs Product Offered
13.6.3 Dechra Veterinary Products Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Dechra Veterinary Products Main Business Overview
13.6.5 Dechra Veterinary Products Latest Developments
13.7 Vetoquinol
13.7.1 Vetoquinol Company Information
13.7.2 Vetoquinol Pet Skin Disease Drugs Product Offered
13.7.3 Vetoquinol Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Vetoquinol Main Business Overview
13.7.5 Vetoquinol Latest Developments
13.8 ALKINLAB
13.8.1 ALKINLAB Company Information
13.8.2 ALKINLAB Pet Skin Disease Drugs Product Offered
13.8.3 ALKINLAB Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ALKINLAB Main Business Overview
13.8.5 ALKINLAB Latest Developments
13.9 Truseb
13.9.1 Truseb Company Information
13.9.2 Truseb Pet Skin Disease Drugs Product Offered
13.9.3 Truseb Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Truseb Main Business Overview
13.9.5 Truseb Latest Developments
13.10 Olewo
13.10.1 Olewo Company Information
13.10.2 Olewo Pet Skin Disease Drugs Product Offered
13.10.3 Olewo Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Olewo Main Business Overview
13.10.5 Olewo Latest Developments
13.11 KANGZHIBO
13.11.1 KANGZHIBO Company Information
13.11.2 KANGZHIBO Pet Skin Disease Drugs Product Offered
13.11.3 KANGZHIBO Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 KANGZHIBO Main Business Overview
13.11.5 KANGZHIBO Latest Developments
13.12 Shanghai Hanvet Bio-Pharm
13.12.1 Shanghai Hanvet Bio-Pharm Company Information
13.12.2 Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Product Offered
13.12.3 Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Shanghai Hanvet Bio-Pharm Main Business Overview
13.12.5 Shanghai Hanvet Bio-Pharm Latest Developments
13.13 DCVET
13.13.1 DCVET Company Information
13.13.2 DCVET Pet Skin Disease Drugs Product Offered
13.13.3 DCVET Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 DCVET Main Business Overview
13.13.5 DCVET Latest Developments
13.14 Nanjing LANBOTO
13.14.1 Nanjing LANBOTO Company Information
13.14.2 Nanjing LANBOTO Pet Skin Disease Drugs Product Offered
13.14.3 Nanjing LANBOTO Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Nanjing LANBOTO Main Business Overview
13.14.5 Nanjing LANBOTO Latest Developments
13.15 Jindun Pharmaceutical
13.15.1 Jindun Pharmaceutical Company Information
13.15.2 Jindun Pharmaceutical Pet Skin Disease Drugs Product Offered
13.15.3 Jindun Pharmaceutical Pet Skin Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Jindun Pharmaceutical Main Business Overview
13.15.5 Jindun Pharmaceutical Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Pet Skin Disease Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet Skin Disease Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Internal Medication
Table 4. Major Players of External Medication
Table 5. Global Pet Skin Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Pet Skin Disease Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Pet Skin Disease Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pet Skin Disease Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Pet Skin Disease Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Pet Skin Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Pet Skin Disease Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Pet Skin Disease Drugs Revenue by Application (2017-2022)
Table 13. Global Pet Skin Disease Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Pet Skin Disease Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Pet Skin Disease Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Pet Skin Disease Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Pet Skin Disease Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pet Skin Disease Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Pet Skin Disease Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Pet Skin Disease Drugs Producing Area Distribution and Sales Area
Table 21. Players Pet Skin Disease Drugs Products Offered
Table 22. Pet Skin Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pet Skin Disease Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Pet Skin Disease Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pet Skin Disease Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pet Skin Disease Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pet Skin Disease Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Pet Skin Disease Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pet Skin Disease Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pet Skin Disease Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pet Skin Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Pet Skin Disease Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Pet Skin Disease Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pet Skin Disease Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Pet Skin Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Pet Skin Disease Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Pet Skin Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Pet Skin Disease Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Pet Skin Disease Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Pet Skin Disease Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Pet Skin Disease Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pet Skin Disease Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Pet Skin Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Pet Skin Disease Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Pet Skin Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Pet Skin Disease Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Pet Skin Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Pet Skin Disease Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Pet Skin Disease Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pet Skin Disease Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Pet Skin Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Pet Skin Disease Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Pet Skin Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Pet Skin Disease Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pet Skin Disease Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Pet Skin Disease Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pet Skin Disease Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pet Skin Disease Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pet Skin Disease Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Pet Skin Disease Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pet Skin Disease Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Pet Skin Disease Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pet Skin Disease Drugs
Table 66. Key Market Challenges & Risks of Pet Skin Disease Drugs
Table 67. Key Industry Trends of Pet Skin Disease Drugs
Table 68. Pet Skin Disease Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pet Skin Disease Drugs Distributors List
Table 71. Pet Skin Disease Drugs Customer List
Table 72. Global Pet Skin Disease Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Pet Skin Disease Drugs Sales Market Forecast by Region
Table 74. Global Pet Skin Disease Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pet Skin Disease Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pet Skin Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Pet Skin Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pet Skin Disease Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Pet Skin Disease Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pet Skin Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Pet Skin Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pet Skin Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Pet Skin Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pet Skin Disease Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Pet Skin Disease Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pet Skin Disease Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pet Skin Disease Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pet Skin Disease Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Pet Skin Disease Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pet Skin Disease Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pet Skin Disease Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Zoetis Animal Health Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Zoetis Animal Health Pet Skin Disease Drugs Product Offered
Table 94. Zoetis Animal Health Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Zoetis Animal Health Main Business
Table 96. Zoetis Animal Health Latest Developments
Table 97. Boehringer Ingelheim Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer Ingelheim Pet Skin Disease Drugs Product Offered
Table 99. Boehringer Ingelheim Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Boehringer Ingelheim Main Business
Table 101. Boehringer Ingelheim Latest Developments
Table 102. Elanco Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Elanco Pet Skin Disease Drugs Product Offered
Table 104. Elanco Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Elanco Main Business
Table 106. Elanco Latest Developments
Table 107. Virbac Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Virbac Pet Skin Disease Drugs Product Offered
Table 109. Virbac Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Virbac Main Business
Table 111. Virbac Latest Developments
Table 112. Norbrook Laboratories Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Norbrook Laboratories Pet Skin Disease Drugs Product Offered
Table 114. Norbrook Laboratories Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Norbrook Laboratories Main Business
Table 116. Norbrook Laboratories Latest Developments
Table 117. Dechra Veterinary Products Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Dechra Veterinary Products Pet Skin Disease Drugs Product Offered
Table 119. Dechra Veterinary Products Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Dechra Veterinary Products Main Business
Table 121. Dechra Veterinary Products Latest Developments
Table 122. Vetoquinol Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Vetoquinol Pet Skin Disease Drugs Product Offered
Table 124. Vetoquinol Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Vetoquinol Main Business
Table 126. Vetoquinol Latest Developments
Table 127. ALKINLAB Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. ALKINLAB Pet Skin Disease Drugs Product Offered
Table 129. ALKINLAB Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. ALKINLAB Main Business
Table 131. ALKINLAB Latest Developments
Table 132. Truseb Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Truseb Pet Skin Disease Drugs Product Offered
Table 134. Truseb Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Truseb Main Business
Table 136. Truseb Latest Developments
Table 137. Olewo Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Olewo Pet Skin Disease Drugs Product Offered
Table 139. Olewo Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Olewo Main Business
Table 141. Olewo Latest Developments
Table 142. KANGZHIBO Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. KANGZHIBO Pet Skin Disease Drugs Product Offered
Table 144. KANGZHIBO Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. KANGZHIBO Main Business
Table 146. KANGZHIBO Latest Developments
Table 147. Shanghai Hanvet Bio-Pharm Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Product Offered
Table 149. Shanghai Hanvet Bio-Pharm Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Shanghai Hanvet Bio-Pharm Main Business
Table 151. Shanghai Hanvet Bio-Pharm Latest Developments
Table 152. DCVET Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. DCVET Pet Skin Disease Drugs Product Offered
Table 154. DCVET Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. DCVET Main Business
Table 156. DCVET Latest Developments
Table 157. Nanjing LANBOTO Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. Nanjing LANBOTO Pet Skin Disease Drugs Product Offered
Table 159. Nanjing LANBOTO Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Nanjing LANBOTO Main Business
Table 161. Nanjing LANBOTO Latest Developments
Table 162. Jindun Pharmaceutical Basic Information, Pet Skin Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Jindun Pharmaceutical Pet Skin Disease Drugs Product Offered
Table 164. Jindun Pharmaceutical Pet Skin Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Jindun Pharmaceutical Main Business
Table 166. Jindun Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Pet Skin Disease Drugs
Figure 2. Pet Skin Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Skin Disease Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pet Skin Disease Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet Skin Disease Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Internal Medication
Figure 10. Product Picture of External Medication
Figure 11. Global Pet Skin Disease Drugs Sales Market Share by Type in 2021
Figure 12. Global Pet Skin Disease Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Pet Skin Disease Drugs Consumed in Parasitic Skin Diseases
Figure 14. Global Pet Skin Disease Drugs Market: Parasitic Skin Diseases (2017-2022) & (K Units)
Figure 15. Pet Skin Disease Drugs Consumed in Fungal Dermatoses
Figure 16. Global Pet Skin Disease Drugs Market: Fungal Dermatoses (2017-2022) & (K Units)
Figure 17. Pet Skin Disease Drugs Consumed in Bacterial Skin Diseases
Figure 18. Global Pet Skin Disease Drugs Market: Bacterial Skin Diseases (2017-2022) & (K Units)
Figure 19. Pet Skin Disease Drugs Consumed in Other
Figure 20. Global Pet Skin Disease Drugs Market: Other (2017-2022) & (K Units)
Figure 21. Global Pet Skin Disease Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global Pet Skin Disease Drugs Revenue Market Share by Application in 2021
Figure 23. Pet Skin Disease Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Pet Skin Disease Drugs Revenue Market Share by Company in 2021
Figure 25. Global Pet Skin Disease Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Pet Skin Disease Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Pet Skin Disease Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Pet Skin Disease Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Pet Skin Disease Drugs Sales 2017-2022 (K Units)
Figure 30. Americas Pet Skin Disease Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Pet Skin Disease Drugs Sales 2017-2022 (K Units)
Figure 32. APAC Pet Skin Disease Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Pet Skin Disease Drugs Sales 2017-2022 (K Units)
Figure 34. Europe Pet Skin Disease Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Pet Skin Disease Drugs Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Pet Skin Disease Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Pet Skin Disease Drugs Sales Market Share by Country in 2021
Figure 38. Americas Pet Skin Disease Drugs Revenue Market Share by Country in 2021
Figure 39. United States Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Pet Skin Disease Drugs Sales Market Share by Region in 2021
Figure 44. APAC Pet Skin Disease Drugs Revenue Market Share by Regions in 2021
Figure 45. China Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Pet Skin Disease Drugs Sales Market Share by Country in 2021
Figure 52. Europe Pet Skin Disease Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Pet Skin Disease Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Pet Skin Disease Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Pet Skin Disease Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Pet Skin Disease Drugs in 2021
Figure 66. Manufacturing Process Analysis of Pet Skin Disease Drugs
Figure 67. Industry Chain Structure of Pet Skin Disease Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles